Evaluating R&D investment efficiency in China's high-tech industry by Han, Chunjia et al.
Evaluating R&D Investment Efficiency in China's High-tech Industry 
 
Dr Chunjia Han (corresponding author) 
Faculty of Business, University of Greenwich, London SE10 9LS, UK 
chunjia1985@gmail.com 
 
Dr Stephen Rhys Thomas 
Southampton Business School, University of Southampton, Highfield, Southampton 
SO17 1BJ, UK 
 
Dr Petros Ieromonachou 
Faculty of Business, University of Greenwich, London SE10 9LS, UK 
 
 
 
 
 
 
 
 
 
 
Evaluating R&D Investment Efficiency in China's High-tech Industry 
Abstract 
Research and development (R&D) investment activity plays a crucial role in 
developing high-tech industries. In recent decades, China has made sustained 
investments in its domestic high-tech industries, with the goal of increasing their 
productivity. This paper investigates the effect of this investment on relative R&D 
efficiency across China’s high-tech sectors. Data Envelopment Analysis (DEA) was 
used to generate quantitative indices for sector comparisons. The analysis of this 
study indicates that overall R&D investment efficiency did not increase from 1998 to 
2009, despite R&D expenditure increasing by 2188%. Over the same period, most 
sectors suffered from decreasing returns to scale (DRS), presumably also reflecting 
the inefficient R&D investment. Most of the sectors showed significant fluctuation 
on R&D investment efficiency. This research result indicates that the problem of 
China’s high-tech industry may be from the inefficiency of its technology 
commercialization processes, and therefore represents a critical parameter for 
policy makers and managers. 
Keywords 
Data Envelopment Analysis (DEA); R&D investment efficiency; China’s high-tech 
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1.1 Introduction 
The importance of innovation has been widely acknowledged and the growth of 
high-tech industry has frequently been regarded as the one of most important 
indices for economic development (Rosegger, 1996; Grossman and Helpman, 1991; 
Cainelli et al., 2006). This phenomenon is no longer confined to the developed 
countries; countries from emerging markets have been investing increasingly into 
the high-tech industry to enhance their capacity for innovation. Although the 
increasing level of investments would seem likely to promote innovation, it is not 
clear that this is occurring (see Zabala-Iturriagagoitia et al., 2007). In addition, 
because of the limitation of resources, investment should be prioritized strategically 
across the various high-tech industries in order to realize optimal levels of 
innovation and productivity.  
Research and development (R&D) activities provide the basis for many corporate 
science and technology activities, and play a crucial role in enhancing the 
competitiveness of companies in achieving sustained and rapid growth (Zhong et 
al., 2011). In order to improve R&D efficiency, it is first necessary to measure it, and 
so quantitative methods have been adapted to analyze the efficiency of R&D 
investment as an index of innovation. R&D investment efficiency is improved when 
for the same amount of R&D input more innovation output is generated, or when 
less R&D input is needed for generating the same amount of innovation output. 
Simply, innovation efficiency can be defined as the ratio of outputs over inputs 
(Hollanders and Celikel-Esser, 2007). Inputs include R&D expenditure, R&D 
personnel and knowledge capital stock, and outputs indicate the technical 
improvement and economic benefit from the R&D activities. 
Measuring the R&D investment efficiency from the quantitative perspective is 
needed to provide practical indices for measuring and managing it, especially in the 
developing countries. Most of the relevant research is based on advanced markets 
in which the innovation production systems are more mature (for example, 
Mansfield, 1998; Timmer, 2003). Although the experiences from these countries 
are very useful, the particular characteristics of emerging markets decide the 
necessity and importance of measuring and understanding the R&D investment 
efficiency in developing countries.  
As one of the main developing countries in the world, China has been making great 
efforts to develop its R&D capacity for high-tech industry. Firstly, China’s 
government figures indicate that spending on R&D has increased dramatically in 
recent years. R&D spending has increased by 2794.044% from 1991 to 2008. Its 
R&D intensity, namely the R&D spending as a percentage of GDP, climbed from 
0.76% in 1999 to 1.54% in 2008. On the global landscape, although China’s global 
share in terms of gross R&D expenditure remains lower, it is currently the second to 
third highest investor in R&D, following the US and Japan. Secondly, from 1995 to 
2004, the number of researchers in China increased by 77%. In 2006, China ranked 
second worldwide with 926,000 researchers, just behind the U.S. and ahead of 
Japan. Thirdly, China’s patent applications and authorizations showed a double-
digit increase, with an average increase of 16.7% and 25%, respectively, from 1986 
to 2007. China’s world-ranking in terms of patent application rose from the 22nd 
place in 1997 to the 7th place in 2007 (China Science and Technology Indicators, 
2009; The Royal Society, 2011). 
With these growing investments aimed at increasing innovation and productivity, 
China has emerged as the largest high-tech exporting country with 16.9% of global 
market share in high-tech products in 2006 (Eurostat’s high-tech statistics, 2009). 
However, China is still far away from the developed countries in independent 
innovation capability and commercialization capability. For example, In terms of 
trade forms, 82% of high-tech exports belong to processing trade in 2009, i.e., 
“processed high-tech” exports. Under the category of high-tech products, what 
China actually exported is low skilled labour rather than technology (Xing, 2011). 
A significant literature about the study of China’s R&D capability has developed over 
the last decade. Zhang et al. (2003) made a contribution about the relationship 
between ownership and R&D efficiency based on a sample of 8341 Chinese firms. 
Guan et al. (2006) studied the relationship between competiveness and 
technological innovation capability based on the analysis of 182 industrial 
innovative firms in China. Liu and Buck (2007) investigated the impact of different 
channels for international technology spill-over on the innovation performance of 
Chinese high-tech industries. Guan and Chen (2010) developed the measurement of 
the innovation production process and applied it to a cross-region study of China’s 
high-tech innovation. Zhong et al. (2011) evaluated the relative efficiencies of 30 
regional R&D investments in 2004.  
Research on the R&D productivity in China began with the studies of elements 
affecting the performance of China’s innovation capability. Later on, researchers 
switched their attention to the measurement of performance on China’s R&D 
productivity. However, the relative studies in the literature only focused on the 
cross-region comparison on R&D investment efficiency. So the research to 
systematically measure the performance of R&D efficiency performance in China’s 
high-tech industry based on industry level and the comparison across sectors and 
sub-sectors is still needed to help understand the innovation capability of China’s 
high-tech industry. 
The main econometric methodologies for efficiency and productivity analysis are 
Data Envelopment Analysis (DEA) and stochastic frontier analysis (SFA). SFA has 
been adapted to develop the studies about the R&D productivity. For example, 
Zhang et al. (2003) applied SFA approach to examine the effects of various types of 
ownership on R&D efficiency of Chinese firms. Wang (2007) applied SFA approach 
to evaluate the relative efficiency of aggregate R&D activities cross 30 countries and 
observed a positive correlation between R&D performance and income level. 
However, there are two disadvantages for SFA technique which make it unsuitable 
for this research: it only can be used when the production function model is known, 
and more importantly it cannot accommodate many inputs and many outputs 
(Avkiran and Rowlands, 2008; Iglesias et al., 2010; Reinhard et al., 2000). DEA, in 
contrast, has several advantages in terms of evaluating the relative efficiency of 
R&D activities: firstly, DEA is especially valuable where therelative importance of the 
various inputs employed andoutputs produced by a DMU (decision making 
units)cannot be deﬁned; secondly, DEA allows for efficiency evaluation without 
necessitating the specification of a functional representation of the R&D/knowledge 
production technology; thirdly, R&D activities typically involves multiple inputs and 
multiple outputs (Wang and Huang, 2007). 
Therefore, Data Envelopment Analysis (DEA) was employed to evaluate the R&D 
investment efficiency in this research. DEA has been widely used to evaluate the 
efficiency and productivity of many different kinds of entities ranging from 
manufacturing industry to service industry, and activities including cost efficiency 
measurement and operating efficiency measurement, as well as in contexts from 
emerging market to advanced market (Cooper et al., 2004). 
Specifically, in this study the following three questions were addressed: Firstly, What 
change did the entire R&D investment efficiency of China’s high-tech industry 
undergo during 1998 to 2009? Secondly, what was the relative performance of 
China’s five major high-tech sectors in terms of R&D investment efficiency? Finally, 
what factors triggered this performance and what are their implications for the 
future performance landscape? 
The remainder of this paper is organized as follows. Section 2.2 explains the 
research design including DEA model, research procedure, variable measurement 
and sample selection. Section 2.3 provides the empirical results of DEA and 
individual output/input ratio analysis applied to the whole industry, the five high-
tech sectors and sixteen sub-sectors.Finally, section 2.4 discusses the results and 
makes the conclusion. 
1.2 Research Design 
1.2.1 The DEA Model 
DEA is a mathematical programming methodology, which is applied to assess 
production efficiency by using multiple inputsand outputs (see,e.g., Kozmetsky and 
Yue,1998; Yeh, 1996). The ground breaking work done by Rousseau and Rousseau 
(1997, 1998) proved the potential of DEA-analysis to assess R&D activities. 
Subsequent studies (see, e.g., Guan and Chen, 2010; Chen et al., 2006; Zabala-
Iturriagagoitia et al., 2007; Zhong et al., 2011) have provided supporting evidence 
for its use in evaluating the innovation efficiency, especially for the high-tech 
industries. Two DEA models are used in this thesis: CCR model (Charnes et al., 
1978) and the BCC model (Banker et al., 1984). The CCR model is designed under 
the assumption that production exhibits constant returns to scale. The BCC model, 
on the other hand, assumes that there are variable returns to scale (Wang and 
Huang, 2007). Therefore, in the CCR model there is a linear relation between inputs 
and outputs; while in the BCC model, outputs can increase by a variable percentage, 
depending on its position on the efficiency frontier (Hollanders and Celikel-Esser, 
2007). The following sectiondescribes the two models in more detail. 
Assume that there are n DMUs (decision making units) (DMU𝑗, 𝑗 = 1,2, … , 𝑛 ). Each 
DMU𝑗 contains m inputs 𝑥𝑖𝑗 (𝑖 = 1,2, … 𝑚) and s outputs𝑦𝑟𝑗  (𝑟 = 1,2, … 𝑠). So the m*n 
input matrix, X, and s*n output matrix, Y, represent the data of all n DMUs. The 
efficiency rate of a unit DMU𝑗 can be generally expressed as: 
weighted sum of outputs
weighted sum of inputs
=
∑ 𝑢𝑟𝑦𝑟𝑗
𝑠
𝑟=1
∑ 𝑣𝑖𝑥𝑖𝑗
𝑚
𝑖=1 ,
 
where𝑢𝑟( 𝑟 = 1,2, … 𝑠)  and 𝑣𝑖 ( 𝑖 = 1,2, … 𝑚)  are separately output weights and input 
weights. The essence of DEA models in measuring the efficiency of productive unit 
DMU𝑗 lies in maximising its efficiency rate but subject to two conditions as follows. 
 The efficiency rate of any other units must not be greater than one. 
 The model must include all characteristics considered, that is the weights of 
all inputs and outputs must not be smaller than zero.  
LetDMU𝑜 be the one to be evaluated. Define u as an s*1 vector of output weights 
(i.e., u=(u1, ⋯ , us)), and v as an m*1 vector of input weights (i.e., v=(v1, ⋯ , vm)). The 
input-output vector of DMU𝑜 is (𝑥𝑜, 𝑦𝑜). To satisfy the two conditions, the general 
DEA model is defined as a linear divisive programming model: 
𝑚𝑎𝑥𝑢,𝑣             (𝑢𝑦𝑜/𝑣𝑥𝑜) 
𝑠𝑢𝑏𝑗𝑒𝑐𝑡 𝑡𝑜     𝑢𝑌/𝑣𝑋 ≤ 1   
                𝑢, 𝑣 ≥ 0                                                                                                                                 (1)     
To make sure the above model has an infinite number of solutions(𝑢, 𝑣), we impose 
𝑣𝑥𝑜 = 1. Then we have 
𝑚𝑎𝑥𝑢,𝑣             (𝑢′𝑦𝑜) 
𝑠𝑢𝑏𝑗𝑒𝑐𝑡 𝑡𝑜       𝑣′𝑥𝑜 = 1   
              𝑢′𝑌 − 𝑣′𝑋 ≤ 0   
                𝑢′, 𝑣′ ≥ 0                                                                                                                                 (2)     
where𝑢′, 𝑣′ are the notions changed from u, 𝑣  reflecting the transformation.  
By using the duality in linear programming, the model (2) can be converted into a 
linear programming model which is called CCR model or BCC model by adding a 
constraint. In particular, let 𝜃 be the efficiency score and 𝜆 bea n*1 vector of 
constants. The CCR model is defined as: 
min𝜃,𝜆  𝜃 
𝑠. 𝑡.    𝜃𝑥𝑜 ≥ 𝑋𝜆 
         𝑌𝜆 ≥ 𝑦𝑜 
    𝜆 ≥ 0                                                                                                                                              (3) 
Here 𝜃 is a scalar and its value is not greater than one. With a value equals to one, it 
indicates such DMU is technically efficient. 
The BCC model adds the convexity constraint. It is shown as follows: 
min𝜃,𝜆  𝜃 
𝑠. 𝑡.    𝜃𝑥𝑜 ≥ 𝑋𝜆 
         𝑌𝜆 ≥ 𝑦𝑜 
  𝚺𝜆 = 1 
𝜆 ≥ 0(4) 
Again, DMU𝑜 is technically efficient if 𝜃 is equal to one. 
1.2.2 Research Procedure 
The study looks at three levels. Firstly, at the industry level it examines the R&D 
investment efficiency of the whole China’s high-tech industry between 1998 and 
2009. Secondly, at the sector level, the performance of five China’s high-tech 
sectors on the R&D investment efficiency from 1998 to 2008 is evaluated. The 
evaluation is based on the DEA test and individual output/input ratio analysis. 
Finally, in order to explore more deeply any  efficiency changes associated with  the 
R&D investment, the performance of 16 sub-sectors over time is examined by 
comparison of the years 2001 and 2008. 
Both the CCR and BCC variants of the DEA model are employed in this research. 
This permits the calculation of the technical efficiency (TE) score, pure technical 
efficiency (PTE) score and scale efficiency (SE) score. The TE score is calculated as 
the ratio of the actual productivity to the maximum attainable productivity (Sharma 
and Thomas, 2008). It is calculated in the CCR DEA model under the assumption of 
constant returns to scale: in this case, the maximum attainable productivity is 
presented as the distance from the constant returns to scale frontier.  The PTE score 
is calculated in the BCC DEA modelas the ratio of the actual productivity to the 
maximum attainable productivity: in this case,the maximum attainable productivity 
represents the distance from the variable returns to scale frontier, which means, in 
contrast to the TE score, the PTE score excludes scale effects (Gulati, 2011). The SE 
score can be derived from the BCC model if the technology exhibits variable returns 
to scale. If there is a difference between the TE score and PTE score for a particular 
sector DMU, then this unit is characterized by scale inefficiency (Wang and Huang, 
2007). The SE score is then defined as the ratio of constant returns to scale 
Technical Efficiency to the Variable Returns to Scale Technical Efficiency (Sharma 
and Thomas, 2008). Once the BCC is established, the analysis can be used to 
determine whether a particular DMU is experiencing increasing, constant, or 
decreasing returns to scale (Chen et al., 2006). Thus the DEA analysis process 
generated three key indices: the SE scores, PTE scores and TE scores. These scores 
can then be used to evaluate the R&D investment efficiency by industry, sector, or 
company over time.  
1.2.3 Variable Measurement and Sample Selection 
1.2.3.1 Input Parameters 
Industrial R&D investment is often a complex process, with multiple inputs and 
outputs. One of the advantages of adopting the DEA analysis is that multiple inputs 
and outputs can be measured more than can be accommodated using conventional 
econometric techniques (Cooper et al., 2004). This multiple DEA analysis study was 
begun by selecting the appropriate inputs and outputs based on the previous 
literature. The inputs to innovation production activities are physical resources and 
mainly manpower, which are usually measured in annual total R&D expenditures 
and R&D personnel (Wang and Huang, 2007).  
The R&D expenditure refers to the total internal expense, covering all projects 
involving fundamental research, applied research or experimental development, as 
well as the ‘overhead’ expenses related to the management and services for these 
projects (Zhong et al., 2011). In this case, the internal expenditure of R&D funding 
is employed to represent the R&D expenditure index. Since the study focuses on 
industrial R&D investment efficiency, only internal expense is included (exclusive of 
external).This R&D expense input index has been widely used, and found to be 
suitable in previous studies (Guan and Chen, 2010; Zhong et al., 2011; Chen et al., 
2006). 
The R&D personnel input figure includes all staff are engaged in either fundamental 
research, application research or experimental development (Zhong et al., 2011). 
The number of research staff on R&D activities can be taken as the R&D personnel 
input index. However, based on the previous studies, the full-time equivalence (FTE) 
cost of scientists and technologists on R&D activities was adopted as the R&D 
personnel input index, since the R&D personnel input index is considered to be 
more accurate than the research staff number. 
However, for the macro-level analysis such as the industry study on country level, 
the effect of knowledge capital stock should also be considered, especially for the 
developing country due to their knowledge capital stock is changing dramatically 
and has strong potential impact to the country’s future innovation performance. 
The support evidence comes from the basic hypothesis behind Romer’s knowledge 
production function (Romer, 1990), which is the idea generation does not ‘‘fall from 
heaven’’, but derives fromprior knowledge stock available and human capital (Guan 
and Chen, 2010).Therefore, knowledge capital stock is employed as the third input 
in this research. The accumulated patents stock is used as a proxy measure of 
knowledge capital stock, which is consistent with prior studies (see Furman et al., 
2002; Hu and Mathews, 2008).  
1.2.3.2 Output Parameters 
The process of innovation production is complex. If we consider all the details in 
this process, it will be impossible to measure its performance. Therefore, the 
former studies tried to simplify the whole process to make it possible to be 
measured, without affecting the final result (see Guan and Chen, 2010). The 
acceptable process could be a system that first obtains technology, then transforms 
the technology into specific product development achievements, and finally to 
output by extending R&D activities to productive development and commercial 
activities (Zhong et al., 2011). So the main outputs of industrial R&D activities are 
not only technical improvements, but also include economic benefits.  
The initial, direct outcome of R&D investment is technical improvement. The patents 
may be the most appropriate proxy of this technical improvement (see Guan and 
Chen, 2010; Wang and Huang, 2007). Although not all inventions are patentable or 
patented and the inventions which are patented have different quality (Griliches, 
1990), former studies including empirical evidence indicate that patents provide a 
fairly reliable measure of innovation production activities (see Acs et al., 2002; 
Pakes and Griliches, 1984). Therefore, this study employed the number of patent 
applications to measure the technical improvement. Here the number of patent 
applications refers to the quantity of accepted patent applications given to the 
sector/sub-sector by the patent office in the given year. 
Economic benefit is the key purpose of company’s R&D investment behaviour. The 
success or failure of innovation activities on economic benefit could be observed 
from the performance of sales and revenues, particularly on new products. As 
Freeman and Soete (1997) discussed, an innovation in theeconomic sense is 
accomplished only with the ﬁrst commercialtransaction. Therefore, two indices – 
value-added from new products and the sale revenue for new products - which 
record the economic performance of new products, are adapted in this research. 
Here value-added from new products refers to the value-added achieved from the 
development of new products in the given year. The sale revenue for new products 
refers to the sale revenue achieved from sales of new products in the given year. 
1.2.3.3 Time Lag Effects 
Previous studies indicated that time lags between the inputs and the outputs could 
be important factors. However, there is no generally accepted time lag for R&D 
inputs and outputs. Goto and Suzuki (1989) studied the average time before the 
sale of a product resulting from R&D technology based on survey data for Japanese 
firms and found that the time lag varied among major industries. Adams and 
Griliches (2000) studied the relationship between research output and R&D in eight 
fields of university research, and considered the time lag to be 5 years. Guellec and 
van Pottelsberghe de la Potterie (2004) considered the lag effects of business and 
public R&D capital stocks on multi-factor productivity growth of 16 countries to be 
1 and 2 years, respectively. Wang and Hua (2007) conducted a preliminary test, 
which showed that a 3-year lag is most appropriate in the study of relative efficiency 
of R&D activities across countries when using aggregate data.Guan and Chen (2010) 
conducted a preliminary test of time lags, using a series of correlation and 
regression analyses, and concluded that the most appropriate time lags for the 
efficiency study of China’s R&D activity would be 2-year lag for the R&D process and 
1-year lag for the commercialization process. Following these studies, the 
preliminary test was given in this study aimed to find the suitable time lag between 
inputs and outputs, which shows that 2-year lag for the applied patent number and 
1-year lag for the value-added from new products and the sale revenue for new 
products are appropriate (For example, if the dataset of the inputs is from the 
statistical data in 2003, the output data of the applied patent number should come 
from the statistical data in 2005 with 2-year lag, and the outputs data of the value-
added from new products and the sale revenue for new products should come from 
the statistical data in 2006 with 1-year lag). 
There are normally two ways to test the robustness of DEA analysis results: firstly, 
by choosing two consecutive cross-sectional datasets to provide an approach for a 
robustness test by longitudinal comparisons (see Guan and Chen, 2010; Zabala-
Iturriagagoitia et al., 2007); secondly, by varying the length of time lags to provide 
a robustness test (e.g., Hollanders and Celikel-Esser, 2007). Due to this study 
utilising panel data, the cross-sectional dataset already included into the data 
analysis. For the other robustness test, two different time lags were selected and 
adapted, in order to see whether current introduction of time lag has an effect of 
the final results. These two time lags are 2 years’ lag which shows that 1-year lag 
for the applied patent number and 1-year lag for the commercial revenue, and 4 
years’ lag which shows 3-year lag for the applied patent number and 1-year lag for 
the commercial revenue. The analysis results show that, although the exact score 
per sector per year has changed, the general performance of each sector looks 
similar which indicates that current introduction of time lag has limited effect on 
the general analysis results. And because this 3 years’ time lag was selected based 
on preliminary test, it is more suitable to be adapted in this study. The analysis of 
results from the other two time lags (2 years’ lag and 4 years’ lag) can been seen in 
the appendix (Table A.1-6). 
Another potential issue is the time lag difference among sectors. The product 
development lead time in different sectors is different (see Arundel et al., 1995). To 
avoid this difference affecting the research result, a test of time lag was needed. 
Based on the above tests which adapted two other time lag choices (2-year time lag 
and 4-year time lag), we can see that for most of sectors the performance and 
ranking are stable in the test results. This indicates that the time lag adopted in this 
study is broadly suitable. However, from the experience in mature market, the 
Medicine sector - as defined in this database - normally has much longer product 
lead time since its characteristics and regulation (see Munos, 2009). Therefore, one 
test was developed through adoption of longer time lag for the Medicine sector to 
observe whether the time lag difference has an effect for the result. 8-year time lag 
was employed in this test,in line with previous studies (Hashimoto and Haneda, 
2008; Odagiri and Murakami; 1992). 
The test result is documented in the Appendix (Table A.7-9). Due to the limitations 
of the time lag effect, only a short period performance of the Medicine sector 
(2003-2008) could be observed. Comparing the research results from four tests of 
time lag, the general performance of the Medicine sector with 8-year time lag is 
consistent with the ones from other tests which showed the trend of improvement 
on R&D efficiency. However, with an 8-year time lag, the R&D efficiency of the 
Medicine sector ranked at second among all sectors, even higher than the 
Electronics sector (EEACE) and the Instrument sector (MEAMI), which was not 
observed at other time lags. With the comparison of expenditure for new product 
development, labour productivity and gross industrial output value, the Medicine 
sector shows lower performance than Electronics sector (see Ministry of Science and 
Technology of the People’s Republic of China, 2011). The differing test results 
indicate that the 8-year time lag is not suitable for China’s medicine sector. The 8-
year time lag is broadly accepted in pharmaceutical industry studies of mature 
markets such as Japan, America and Europe (for example Hashimoto and Haneda, 
2008). However, comparing with mature markets, the China’s medicine sector has a 
different situation. China was still staying at the imitative innovation stage in their 
pharmaceutical industry during the test period of 1993-2008 (Ding et al., 2011). 
One of the potential explanations is that the time required for clinical trials and 
drug approvals in China is shorter than time in mature markets (Wang and Kang, 
2005). Therefore, based on the analysis, the time lag of the Medicine sector 
adapted in this research is consistent with the one for other sectors. 
1.2.3.4 Data Sources 
As the subject of this first study is China’s high-tech industry, both data of inputs 
and outputsfrom 1995-2009 were taken from China’s Statistics Yearbook on High-
tech industries, as compiled by the Chinese State Statistical Bureau. China’s high-
tech industry is divided into 5 sectors and 21 sub-sectors according to the 
categorization in the yearbook. The dataset includes the sectors of Manufacture of 
Medicines (with 3 sub-sectors), Manufacture of Aircraft and Spacecraft (with 2 sub-
sectors), Manufacture of Electronic Equipment and Communication Equipment (11 
sub-sectors), Manufacture of Computers and Office Equipment (with 3 sub-sectors), 
and Manufacture of Medical Equipment and Measuring Instrument (with 2 sub-
sectors). Their categorization of China’s high-tech industry in that yearbook is 
shown in Table 2.1. Based on that categorization, the R&D investment efficiency 
could be analysed at three distinct levels: the whole high-tech industry, the five big 
high-tech sectors and the 16 high-tech sub-sectors. The primary results are 
summarized below. This is the most up-to-date and detailed data on China’s high-
tech industry currently available.  
All financial inputs and outputs were expressed in Chinese currency, as 10,000s 
RMB$ Since the duration of the sample period was more than ten years, the 
expenditure indicators  were adjusted by comparable price index in 1995, to 
remove the inflation impact over period.The basic statistics for the main variables 
used to study the R&D performance of China’s high-tech industry from three levels 
(whole industry, sectors and sub-sectors) are reported respectively in Table 2.2, 
Table 2.3 and Table 2.4.  
Table 0.1: Categories of China’s high-tech industry 
NO. 
 
Sectors Abbr. NO. Sub-sectors* 
1 Manufacture of Medicines Medicines 1 Manufacture of Chemical Medicine 
2 Manufacture of Finished Traditional Chinese 
Herbal Medicine 
3 Manufacture of Biological and Biochemical 
Chemical Products 
2 Manufacture of Aircrafts and 
Spacecraft 
AAS 
 
 
4 Manufacture and Repairing of Airplanes 
5 Manufacture of Spacecraft 
3 
 
Manufacture of Electronic 
Equipment and 
Communication Equipment 
 
EEACE 6 Manufacture of Communication Transmitting 
Equipment 
7 Manufacture of Communication Exchanging 
Equipment 
8 Manufacture of Communication Terminal 
Equipment 
9 Manufacture of Radar and its Fittings 
10 Manufacture of Broadcasting and TV Equipment 
11 Manufacture of Electronic Vacuum Appliances 
12 Manufacture of Semiconductor Appliances 
13 Manufacture of Integrate Circuit 
14 Manufacture of Electronic Components 
15 Manufacture of Domestic TV Sets and Radio 
Receivers 
16 Manufacture of Other Electronic Equipment 
4 Manufacture of Computers 
and Office Equipment 
CAOE 17 Manufacture of Entire Computer 
18 Manufacture of Computer Peripheral Equipment 
19 Manufacture of Office Equipment 
5 Manufacture of Medical 
Equipment and Measuring 
Instrument 
MEAMI 20 Manufacture of Medical Equipment and 
Appliances 
21 Manufacture of Measuring Instrument 
*There are 21 sub-sectors in categories of China’s high-tech industry. Due to the lack of data in some sub-
sectors, only 16 sub-sectors met the completeness criteria for this research. (Sub-sectors NO. 5, 7, 9, 10, 19 
were excluded). 
Table 0.2: Descriptive statistics for main variables in the whole industry study 
Variables Mean 
Standard 
deviation  
Maximum Minimum 
R&D expenditure  1616497 1296985.664 4084257.48 178474.1 
Full-time equivalent of R&D 
personnel  
111700.7 38337.46342 188986.54 57838 
Accumulated patents stock  2518 2627.829523 8141 312 
Patent applications  12417.25 13564.50523 39656 713 
Value-added from new 
products  
56663054 33088083.42 107298051 14243655 
Sale revenue for new products  55305287 33364143.32 108102978.8 12272350 
Sample size of DMU 12    
Data sources: Data comes from China Statistics Yearbook on High-tech industries, as compiled 
by the Chinese State Statistical Bureau. China’s high-tech industry is divided into 5 sectors and 
21 sub-sectors according to the categorization in the yearbook. This is the descriptive 
statistics of data in the first level study about the whole China's high-tech industry. Here the 
unit of R&D expenditure, value-added from new products and sale revenue for new products 
is 10,000 RMB$; the unit of patent applications and accumulated patent stock is item. 
 
 
Table 0.3: Descriptive statistics for main variables in 16 sub-sectors study 
Variables Mean 
Standard 
deviation  Maximum Minimum 
R&D expenditure (2001) 23305 24029.9 88187.82 2944.948 
R&D personnel (2001) 3343.875 3520.659 14425 844 
Accumulated patents stock (2001) 44.625 56.74725 175 4 
Patent applications (2001) 106.4375 98.98079 331 6 
Value-added from new products (2001) 1696668 2145986 7447041 132983.9 
Sale revenue for new products (2001) 1648856 2039920 6811947 106166.1 
R&D expenditure (2008) 137491.6 119556.2 461649.2 18802.78 
R&D personnel (2008) 7373.378 6841.567 27720.36 1262.46 
Accumulated patents stock (2008) 229.5 181.1706 501 11 
Patent applications (2008) 1074.938 920.0535 3614 47 
Value-added from new products (2008) 4732791 5812012 20841837 629713.7 
Sale revenue for new products (2008) 4650793 5812697 20279665 584431.5 
Sample size of DMU 55    
Data sources: Data comes from China Statistics Yearbook on High-tech industries, as compiled 
by the Chinese State Statistical Bureau. China’s high-tech industry is divided into 5 sectors and 
21 sub-sectors according to the categorization in the yearbook. This is the descriptive 
statistics of data in the third level study about the comparison research of 16 sub-sectors 
from China's high-tech industry in 2001 and 2008. Here the unit of R&D expenditure, value-
added from new products and sale revenue for new products is 10,000 RMB$; the unit of 
patent applications and accumulated patent stock is item. 
 
Table 0.4: Descriptive statistics for main variables in five sectors study 
Variables Mean Standard Maximum Minimum 
deviation  
R&D expenditure (Medicines) 165645.2 110542.9 368216 42785 
R&D personnel (Medicines) 13841.83 3370.09 19584.38 9528 
Accumulated patents stock (Medicines) 417 326.526 1134 113 
Patent applications (Medicines) 1294.909 1026.891 3056 257 
Value-added from new products 
(Medicines) 3866045 2261652 8279468 1273707 
Sale revenue for new products 
(Medicines) 3536810 2130015 7705194 1056384 
R&D expenditure (AAS) 152167.6 76563.53 256195.5 65067 
R&D personnel (AAS) 30680.5 6758.321 40748 18145 
Accumulated patents stock (AAS) 108.7273 51.74957 192 38 
Patent applications (AAS) 247.2727 229.9 810 79 
Value-added from new products (AAS) 2095044 1227502 3822463 428448.7 
Sale revenue for new products (AAS) 1952164 1193183 3840623 352557.1 
R&D expenditure (EEACE) 859331.6 725592.8 2163308 51289 
R&D personnel (EEACE) 44156.15 22345.48 95091.24 15398 
Accumulated patents stock (EEACE) 1104 1326.545 4268 84 
Patent applications (EEACE) 6499.091 7946.413 24680 243 
Value-added from new products (EEACE) 30395572 15549722 54364062 9887901 
Sale revenue for new products (EEACE) 29618161 15819338 54883987 8173422 
R&D expenditure (CAOE) 159545.3 142948.5 400446.3 5473 
R&D personnel (CAOE) 7647.945 4863.667 17483.75 1355 
Accumulated patents stock (CAOE) 171.1818 227.9126 711 6 
Patent applications (CAOE) 1177.727 1178.783 3266 34 
Value-added from new products (CAOE) 14116942 10742944 35056725 2228038 
Sale revenue for new products (CAOE) 13903414 10645668 34329416 2293097 
R&D expenditure (MEAMI) 55466.04 42979.41 152869.9 13860 
R&D personnel (MEAMI) 8348.066 1094.947 11132.08 6788 
Accumulated patents stock (MEAMI) 205.9091 177.1798 591 41 
Patent applications (MEAMI) 722 756.983 2634 100 
Value-added from new products (MEAMI) 1586269 1242651 4186301 425559.7 
Sale revenue for new products (MEAMI) 1494948 1158180 3822655 396889.9 
Sample size of DMU 32    
Data sources: Data comes from China Statistics Yearbook on High-tech industries, as 
compiled by the Chinese State Statistical Bureau. China’s high-tech industry is divided into 5 
sectors and 21 sub-sectors according to the categorization in the yearbook. This is the 
descriptive statistics of data in the second level study about the five sectors in China's high-
tech industry. Here the unit of R&D expenditure, value-added from new products and sale 
revenue for new products is 10,000 RMB$; the unit of patent applications and accumulated 
patent stock is item. 
1.3 Empirical Results 
1.3.1 Overall Efficiency of China’s High-tech Industry 
The R&D investment efficiency across the high-tech industry sectors was examined 
for the period 1998 to 2009, and the final results, including TE score, PTE score and 
SE score are summarized in Table 2.5. Examination at the whole high-tech industry 
level indicates that the R&D investment efficiency in China’s high-tech industry was 
mostly unchanged over the period 1998 to 2009 (see Table 2.5). This was despite 
rising R&D expenditure over the period.  
Table 0.5: Efficiency scores and returns to scale of the whole high-tech industry in 
years 1998-2009 
Year 
Technical 
Efficiency 
Pure 
Technical 
Efficiency 
Scale 
Efficiency 
Returns 
To Scale 
1998 1 1 1 - 
1999 0.904 1 0.904 irs 
2000 1 1 1 - 
2001 1 1 1 - 
2002 1 1 1 - 
2003 1 1 1 - 
2004 1 1 1 - 
2005 1 1 1 - 
2006 0.948 0.975 0.973 drs 
2007 1 1 1 - 
2008 1 1 1 - 
2009 1 1 1 - 
Average 0.988 0.998 0.99   
irs and drs stand for increasing and decreasing returns 
to scale, respectively. 
 
The only two obvious changes were the downturns in years 1999 and 2006. Both of 
these appear to result from reductions in Scale Efficiency (SE); however, the first 
downturn was associated with increasing returns to scale (IRS) and the second with 
decreasing returns to scale (DRS). Except for these two years, all the other R&D 
investment efficiencies from 1998 to 2009 were unchanged. The potential 
conclusion is that, even with more than ten yearsdevelopment, the R&D investment 
efficiency in China’s high-tech industry has not exhibited any dramatic improvement.  
1.3.2 Patents Performance 
This result suggests a disappointing prospect for the development of China’s high-
tech industry investment. To investigate further the factors which may underlie the 
unchanged efficiency, the growth ratios of the inputs and outputs were analysed 
further (Figure 2.1). This analysis showed that although increasing R&D expenditure 
appeared to be correlated with a dramatic increase in the number of patent 
applications, there only appeared to be a limited economic benefit in terms of new 
high-tech product revenues. This finding in turn may suggest that although 
increasing R&D investment (inputs) does appear to have improved the efficiency of 
technology production in terms of patents, this improvement did not result in a 
complementary increase in new product revenue, suggesting that the 
commercialization process for technology was still inefficient. Thiswould explain, at 
least in part, the flat R&D performance of the whole high-tech industry over the 
period of observation. However, this does not rule out a positive longer-term effect; 
this point is revisited in the discussion. 
 
Figure 0.1: The growth ratio of R&D investment inputs and outputs 
1.3.3 Further Analysis 
1.3.3.1 Technical Efficiency 
The TE scores reflect the overall R&D investment efficiency. Most of the sectors 
showed significant fluctuation over the period (see Table 2.6 and Figure 2.2). The 
R&D investment efficiency of the Computer sector (CAOE) was consistently the 
highest until 2006. The Electronics sector (EEACE) and the Instrument sector (MEAMI) 
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The calculation of growth ratio is based on the data of 1998. all the indicators from the other years compared
with the data from 1998. for example, the patent stock growth ratio (2007)=(patent stock 2007-patent stock
1998)/patent stock 1998.
followed the Computer sector until 2006, but then overtook it in 2007 and 2008. 
Aerospace (AAS) was the lowest-performing sector of the five high-tech sectors. 
Table 0.6: Technical efficiency scores of five sectors in years 1998-2008 
Year Medicines AAS EEACE CAOE MEAMI 
1998 0.381 0.102 0.598 1 0.459 
1999 0.373 0.141 0.525 1 0.507 
2000 0.333 0.157 0.634 0.72 0.706 
2001 0.468 0.089 0.411 0.833 0.643 
2002 0.538 0.139 0.46 0.765 0.571 
2003 0.473 0.123 0.43 1 0.693 
2004 0.533 0.199 0.506 1 0.622 
2005 0.55 0.096 0.663 1 0.993 
2006 0.771 0.172 0.745 0.956 0.632 
2007 0.689 0.339 1 0.951 0.859 
2008 0.633 0.341 1 0.887 1 
Average 0.522 0.173 0.634 0.919 0.699 
Rank 4 5 3 1 2 
 
Figure 0.2: The annual variation of the R&D investment TE in five high-tech sectors 
from 1998 to 2008 
1.3.3.2 Pure Technical Efficiency (PTE) 
The PTE scores, which reflect the pure R&D investment efficiency excluding scale 
effects, showed a similar pattern of fluctuation and change to the TE analysis. The 
Computer sector achieved the highest and most consistent PTE scores from 1998 
through to 2008 (see Table 2.7 and Figure 2.3). The PTE scores of the Electronics 
sector were the second highest but fluctuated more over the period. All the other 
three sectors showed an improvement in their PTE scores over the period. Over this 
period, the Aerospace sector also had the lowest PET scores, echoing the pattern of 
TE results. 
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Table 0.7: Pure technical efficiency scores of five high-tech sectors in years 1998-
2008 
Year Medicines AAS EEACE CAOE  MEAMI 
1998 0.393 0.104 1 1 0.55 
1999 0.381 0.144 0.818 1 0.566 
2000 0.335 0.162 1 0.792 0.782 
2001 0.47 0.111 0.759 1 0.694 
2002 0.539 0.163 0.794 0.874 0.605 
2003 0.474 0.153 0.838 1 0.72 
2004 0.572 0.206 1 1 0.634 
2005 0.588 0.165 0.936 1 1 
2006 0.846 0.193 0.808 1 0.637 
2007 0.689 0.353 1 1 0.869 
2008 0.647 0.402 1 1 1 
Average 0.539 0.196 0.905 0.97 0.732 
Rank 4 5 2 1 3 
 
Figure 0.3: The annual variation of the R&D investment PTE in five high-tech sectors 
from 1998 to 2008 
1.3.3.3 Scale Efficiency (SE) 
Scale efficiency (SE) scores, which reflect various classes of the returns to scale of 
R&D investment, didnot show any consistent pattern of change across the sectors 
during this period. SE was highest in the Medicine sector, followed by Instrument 
and Computer sectors (see Table 2.8 and Figure 2.4).  
Table 0.8: Scale efficiency scores and returns to scale of five high-tech sectors in 
years 1998-2008 
  Medicines AAS  EEACE CAOE  MEAMI 
Year SE RTS SE RTS SE RTS SE RTS SE RTS 
1998 0.97 drs 0.984 irs 0.598 drs 1 - 0.835 Irs 
1999 0.978 irs 0.981 irs 0.642 drs 1 - 0.896 Irs 
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2000 0.995 drs 0.966 irs 0.634 drs 0.909 drs 0.903 Irs 
2001 0.995 irs 0.796 drs 0.542 drs 0.833 drs 0.928 Irs 
2002 0.998 irs 0.85 drs 0.579 drs 0.875 drs 0.944 Irs 
2003 0.999 drs 0.801 drs 0.513 drs 1 - 0.963 Irs 
2004 0.932 drs 0.966 drs 0.506 drs 1 - 0.981 Irs 
2005 0.935 drs 0.583 drs 0.708 drs 1 - 0.993 Irs 
2006 0.911 drs 0.892 drs 0.921 drs 0.956 drs 0.993 Drs 
2007 1 - 0.958 drs 1 - 0.951 drs 0.988 Drs 
2008 0.978 drs 0.848 drs 1 - 0.887 drs 1 - 
Average 0.972 
 
0.875 
 
0.695 
 
0.946 
 
0.948 
 
Rank 1   4   5   3   2   
RTS is returns to scale. irs and drs for increasingand decreasing returns to scale, 
respectively. 
 
Figure 0.4: The annual variation of the scale efficiency scores in five high-tech 
sectors from 1998 to 2008 
The average SE scores of the Electronics sector was the lowest of all the high-tech 
sectors althoughit has begun to increase since 2005. At the same time, the SE score 
of the Computer sector started to decline. Based on the observation of the SE score 
progress, the initial conclusionis that there appears no marked difference in returns 
to scale across the sector during this period.  Further analysis of the SE data 
indicated that returns to scale (RS) metrics could provide useful indices for the 
management of R&D investment efficiency. There are three possible classes of 
returns to scale: decreasing (DRS), increasing (IRS) and constant (CRS). CRS is 
indicated by an SE score of 1; DRS, signified by a decrease in the relative output for 
a given incremental input, and an associated decline in the consequent 
revenue/profit. The policy implications for such a sector appear to be that active 
monitoring and management of RS metrics may provide useful indices for 
controland allocation of R&D investment. IRS, signified by an increase in the relative 
output for a given incremental input, suggests that for such a sector the incumbent 
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R&D investment is insufficient to fully utilize the potential production capacity, 
therefore making the sector suffer from scale inefficiency. China’s high-tech sectors 
suffered from DRS for most of the test period, with the exception of the Instrument 
sector. The Electronics and Instrument sectors both saw CRS, signifying the best 
scale efficiency performance in 2008; Electronics, suffered from DRS before 2007, 
whereasthe Instrument sector suffered from IRS before 2006.  
In summary, it appears that most of the high-tech sectors in China have been 
suffering from decreasing returns to scale over the decade 1998-2008. This DRS 
trend may be a consequence of uncontrolled expansion of enterprises in these 
sectors, and/or increasing intensity of market competition. Another possible 
explanation is the monopolistic position of the high-tech sector in China, effectively 
reducing/removing competition.  
1.3.3.4 Individual Output/Input Ratio Analysis 
As shown in Table 2.9 and Table 2.10, ratio analysis was employed to examine the 
differences on individual output/input items among the five sectors. Table 2.6 
presents the ratios of number of patents over the three inputs respectively: R&D 
expenditure,R&D personneland the accumulated patents stock. Here, sectors 1 to 5 
represent the Medicines sector, Aerospace sector, Electronics sector, Computer 
sector, Instrument sector, respectively. 
Table 0.9: Individual output/input ratio analysis in terms of number of patents in 
years 1998-2008 
 
Table 6
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
sector 1 0.027 0.025 0.025 0.050 0.056 0.082 0.086 0.093 0.155 0.171 0.156 0.084 3
sector 2 0.003 0.003 0.002 0.004 0.003 0.006 0.009 0.004 0.012 0.021 0.027 0.009 5
sector 3 0.016 0.018 0.026 0.036 0.053 0.081 0.099 0.141 0.179 0.276 0.260 0.108 2
sector 4 0.025 0.019 0.018 0.065 0.091 0.242 0.186 0.202 0.150 0.237 0.187 0.129 1
sector 5 0.015 0.015 0.028 0.033 0.038 0.063 0.066 0.109 0.111 0.168 0.237 0.080 4
sector 1 0.006 0.005 0.004 0.007 0.008 0.007 0.007 0.007 0.010 0.009 0.008 0.007 4
sector 2 0.001 0.001 0.001 0.001 0.001 0.001 0.002 0.001 0.001 0.002 0.003 0.001 5
sector 3 0.005 0.004 0.004 0.003 0.004 0.004 0.005 0.006 0.008 0.009 0.011 0.010 2
sector 4 0.006 0.004 0.002 0.006 0.007 0.008 0.011 0.005 0.007 0.008 0.008 0.009 3
sector 5 0.007 0.007 0.011 0.010 0.010 0.012 0.010 0.013 0.011 0.014 0.017 0.016 1
sector 1 1.404 2.434 2.112 2.442 3.168 2.413 4.237 3.504 5.900 2.642 2.695 2.996 4
sector 2 0.908 1.946 2.447 0.434 1.737 1.266 2.686 1.230 2.326 6.986 4.219 2.381 5
sector 3 2.893 4.958 7.989 4.618 5.150 5.019 5.906 6.541 5.249 6.811 5.783 5.538 2
sector 4 3.778 13.50 10.69 5.596 8.087 7.275 10.81 35.11 6.875 4.530 6.905 10.29 1
sector 5 2.128 3.293 3.484 3.213 1.913 2.976 2.792 6.333 2.343 3.735 4.457 3.333 3
ranksector
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Table 2.10 shows that: (1) The Computer sector performed at the best level on R&D 
personnel ratio and patent stocks ratio. (2) The Instrument sector ranked first in 
R&D expenditure ratio but did not perform well in the other ratios. (3) The 
Electronics sector ranked second in all output/input ratios. (4) The Aerospace sector 
operated least efficient among the five sectors. (5) The Medicines sector performed 
only better than the Aerospace sector. Noticeably, it ranked third in the R&D 
personnel ratio due to its consecutive increase in full-time equivalence productivity 
on patents between 2001 and 2007. 
Table 2.10 represents the ratios of new product annual sales to three outputs in 
each industry: R&D expenditure, R&D personnel and the accumulated patents stock. 
This analysis shows that the Computer sector and Electronics sector ranked first 
and second across every ratio. The Medicines sector and Instrument sector operated 
less efficiently, and again the Aerospace sector exhibited the lowest performance. 
This analysis supports the initial conclusion from the earlier analyses that the 
Computer sector is the most efficient sector within China’s high-tech industry, 
followed with the Electronics sector and Instrument sector; the Aerospace sector 
has the worst performance on R&D investment efficiency. 
Table 0.10: Individual output/input ratio analysis in terms of new product annual 
sales in years 1998-2008 
 
1.3.3.5 Summary of Analysis: Sector-level Indices 
Based on the analysis of the TE, PTE, SE and output/input ratio, the Computer sector 
achieved the best R&D investment efficiency among China’s five biggest high-tech 
sectors. However, apparently suffering from decreasing returns to scale, its 
Table 7
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
sector 1 110.87 113.78 152.62 191.02 200.68 256.8 246.81 237.43 291.1 444.1 393.4 239.88 3
sector 2 14.234 14.708 20.222 54.349 44.81 71.58 64.014 86.101 96.91 137 128.6 66.5895 5
sector 3 530.81 361.06 579 639.8 729.48 819.8 790.52 714.71 605.8 862.5 577.2 655.514 2
sector 4 1692.3 868.01 710.29 1603.7 1286.9 2486 1941.7 2895.6 2139 1799 1964 1762.48 1
sector 5 58.469 62.735 83.255 93.43 83.929 146.8 150.41 218.12 261.3 379.2 343.4 171.003 4
sector 1 24.691 22.673 26.744 26.694 27.079 22.84 19.019 19.05 17.96 22.7 20.93 22.7624 4
sector 2 5.4184 6.1262 10.224 13.765 16.617 15.79 12.116 13.29 11.95 13.48 14.99 12.161 5
sector 3 159.36 85.849 94.808 54.541 57.206 43.61 35.993 30.159 26.28 28.63 25.37 58.3461 2
sector 4 418.98 205.55 76.859 141.49 99.069 83.7 118.02 73.187 100.4 63.81 85.73 133.341 1
sector 5 28.636 28.77 33.568 28.382 21.149 27.19 23.719 27.023 25.04 32.63 25.01 27.3737 3
sector 1 5772.6 11012 12873 9261.2 11258 7529 12203 8937.9 11110 6858 6795 9419.18 4
sector 2 4052.4 10292 21684 5418.5 26361 15879 19568 24677 19359 45081 20003 19306.8 3
sector 3 97303 101978 175781 80994 71024 50975 47021 33243 17783 21277 12859 64567 2
sector 4 254789 618894 418527 137442 114501 74797 112838 502089 97839 34363 72578 221696 1
sector 5 8444.5 13891 10528 9012.5 4255.3 6941 6347.1 12686 5516 8409 6468 8408.89 5
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efficiency has been declining since 2006. On present trends, the Electronics sector 
and Instrument sector might be predicted to overtake the Computer sector, as the 
best R&D investment efficient high-tech sector in China, based on their performance 
in the test of DEA and output/input ratio. The other two sectors - medicines sector 
and Aerospace sector have been suffering from low R&D investment efficiency, 
which may come from the effects of monopoly, and may call into question that 
investment strategy. 
1.3.4 Detailed Sub-sector Analysis 
Following on from the sector-level ratio analysis, the R&D investment efficiency 
within specific sub-sectors was moved on to explore. Of the 21 high-tech sub-
sectors covered in the Bureau data, only 16 could be accepted into analysis: 5 had 
to be excluded because of incomplete data. More detailed analysis of the 16 
defined sub-sectors revealed that their individual R&D investment efficiencies 
changed dramatically in year 2001 and 2008.  
The overall pattern which emerges from the sub-sector analysis is of gradual decline 
in TE and PTE, some rise in SE and a fairly dramatic rise in the number of sub-
sectors undergoing DRS. Over the same sample period, average SE scores across 
the sub-sectors were increasing, and the number of sub-sectors which were 
suffering from DRS rose dramatically. In addition, fewer sub-sectors were 
performing with high R&D investment efficiency (see Table 2.11). In Figure2.5(a) 
and 2.5(b), the distribution of PTE/TE ratios was plotted, and indicate their 
relationship to the average PTE and TE scores (solid lines).In Figure 2.6(a) and 2.6(b), 
the situation as a series of four-quadrant grids framing the potential zones of 
behaviour between key parameters was portrayed. The positive relationship 
between TE score and PTE score in Figure2.5a could be observed. And the 
relationship is much stronger in Figure2.5b, which suggests the PTE level is more 
important in improving the TE score.  
In Figure 2.5a: (1) The lines perpendicular to the x-axis and the y-axis are, 
respectively, the average value of the TE score and PTE score for the 16 high-tech 
sectors, (2) The numbered points on the grid represent the individual sectors 
represented in table 2.11. 
In Figure 2.5b: (1) the lines which are perpendicular to the x-axis and the y-axis are, 
respectively, average value of TE and PTE scores of 16 sub-sectors, that is x=0.599, 
y=0.747. (2) The numbers represent the various sub-sectors in Table 2.11. Figure 
2.5b shows the equivalent data for 2008 on the same axes. 
In both Figure 2.5a and 2.5b, the sectors in zone A exhibit both high PTE and TE 
scores. Sectors in zone B show high PTE scores, but low TE scores. Zone C sectors 
exhibit low score on both PTE and TE. There are few sectors in zone D, making high 
TE score with low PTE level an uncommon occurrence. 
Table 0.11: Process efficiency scores of R&D investment in 16 China's high-tech 
sub-sectors in 2001 and 2008 
Ind. 
*Sub-
sector 
NO. 
Abbr. TE   PTE   SE   RTS 
      2001 2008 
 
2001 2008 
 
2001 2008 
 
2001 2008 
medicines 
1 CM 0.533 0.314 
 
0.97 0.54 
 
0.55 0.581 
 
drs Drs 
2 FTCHM 1 0.551 
 
1 0.959 
 
1 0.575 
 
- Drs 
3 BABCP 0.429 0.562 
 
1 0.575 
 
0.429 0.977 
 
irs Irs 
AAS  4 ROA 0.104 0.234   0.237 0.413   0.44 0.566   drs Drs 
EEACE 
6 CTRE 0.363 0.535 
 
0.375 0.787 
 
0.967 0.68 
 
irs Drs 
8 CTEE 1 0.252 
 
1 0.255 
 
1 0.987 
 
- Irs 
11 EVA 0.672 0.389 
 
0.778 0.394 
 
0.863 0.986 
 
irs Irs 
12 SDA 0.245 0.335 
 
1 0.469 
 
0.245 0.715 
 
irs Irs 
13 IC 0.399 0.786 
 
1 1 
 
0.399 0.786 
 
irs Drs 
14 ELC 0.418 0.367 
 
0.544 0.585 
 
0.77 0.628 
 
drs Drs 
15 DTSARR 1 0.816 
 
1 1 
 
1 0.816 
 
- Drs 
16 OEE 0.576 1 
 
1 1 
 
0.576 1 
 
irs - 
CAOE 
17 ENC 1 1   1 1   1 1   - - 
18 CPE 0.869 0.88   0.926 1   0.939 0.88   drs Drs 
MEAMI 
20 MEAA 1 1 
 
1 1 
 
1 1 
 
- - 
21 MI 0.689 0.564 
 
0.85 0.977 
 
0.811 0.577 
 
drs Drs 
  mean   0.644 0.599   0.855 0.747   0.749 0.797       
*The sub-sector No. corresponds with those shown in Table 2.1, and represents the same sub-sectors 
with the numbers shown in Figure 2.5 and Figure 2.6. 
 
Figure 2.6 shows the shift in the PTE and TE scores of the 16 sub-sectors between 
2001 and 2008. This analysis reveals no sub-sector staying in Zones B or C in 2008; 
more sub-sectors appear in Zone A and B. These changes indicate that the overall 
Scale efficiency level across the 16 sub-sectors improved, which may be the 
consequence of the consistent increase of R&D investment inputs in China. However, 
a decline of the PTE level across these sub-sectors accompanied the SE 
improvement, which again highlights the importance of PTE improvement as a key 
management index for the increasing of overall R&D investment efficiency level 
within China’s high-tech sub-sectors. 
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 Figure 0.6: The comparison of PTE and SE scores of 16 sub-sectors in 2001 and 
2008 
There are three sub-sectors in the Medicine sector: Chemical Medicine, Herbal 
Medicine, and Biological Products. Chemical Medicine sub-sector (CM) and Herbal 
Medicine sub-sector (FTCHM), which were separately suffering from the decreasing 
of PTE and CE experienced the decreasing R&D efficiency. Biological Products sub-
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sector (BABCP) which was benefit from the great improvement of its CE, improved a 
little in its TE. Airplanes sub-sector (ORA) -- part of the Aerospace sector, improved 
its R&D investment efficiency through the development of both PTE and CE. In the 
Electronics sector, four sub-sectors (CTRE, SDA, IC, and OEE) which most benefited 
from the improvement of PTE, increased their TE score during year 2001 to 2008. 
The other four sub-sectors in Electronics sector experienced the decreasing of TE 
based on different reasons. Entire Computer sub-sector (ENC) from the Computer 
sector and Medical Equipment sub-sector (MEAA) from the Instrument sector were 
the most efficient sub-sectors about R&D investment both in year 2001 and 2008. 
 
 
 
 
 
 
 
 
 
 
 
 
Based on the above study, a model (see figure 2.7) is designed to help industries 
evaluate their positions on these key indices of innovation and identify the most 
appropriate actionable strategies/steps to improve their R&D investment efficiency. 
Dragon Zone sectors are in a strong position: for sectors in this zone, the amount 
of R&D investment input is sufficient, leading to the best returns to the scale; the 
capacity of resource allocation and innovation productivity is near optimal, leading 
to highest R&D investment output. This is the desired goal for most if not all 
sectors each. 
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Figure 0.7: Proposed strategy grid for companies/sectors with varying levels of 
technical efficiency and scale 
Tiger Zone: for sectors in this zone, the capacity of resource allocation and 
innovation productivity is also approaching the optimum, favouring  high R&D 
investment output, but the level  of R&D investment inputs is suboptimal  leading to 
decreasing or increasing returns to the scale scenarios (DRS or IRS). To move to the 
Dragon zone, companies in the Tiger zone, firstly need to identify the polarity of 
their scale inefficiency – decreasing returns to the scale (DRS) which implies R&D 
investment inputs have been used inefficiently, or increasing returns to the scale 
(IRS) which suggests  R&D investment inputs is insufficient to exploit fully the 
company/sector’s capacity.  Secondly, based on the earlier analysis, 
companies/sectors could adopt a different course of action – increasing R&D 
investment inputs if suffering from IRS, or decreasing R&D investment inputs if the 
industry is showing signs of DRS effects.  
Ox Zone: for companies/sectors in this zone, the amount of R&D investment input 
is sufficient but not excessive, leading to the best returns to scale. But resource 
allocation and innovation productivity is relatively weak, producing the observed 
R&D investment inefficiency. Sectors or companies in this zone need to apply R&D 
investment more efficiently, and improvinginnovation productivity is the main 
approach. 
Rabbit Zone: companies or sectors in this zone are likely to have issues both on the 
scale of R&D investment and innovation productivity.The immediate needs are 
therefore to judge which scale problem is in effect - IRS or DRS,then attempt to 
change the quality and level of the R&D investment inputs, and also concentrate on 
improving the pure technical efficiency.  
For policy makers, the findings and the proposed model suggest that companies or 
sectors: 
(1) Keep the advantage of ‘Dragon’ industries, which is the most efficient engine for 
economic growth; 
(2) Give policy support to help control the R&D investment inputs in ‘Tiger’ 
industries, which are the potential high efficient engine for economic growth;  
(3) Help to control the R&D investment inputs in ‘Rabbit’ industry, that is the fast 
way to improve their R&D investment efficiency;  
(4) Help both ‘Rabbit’ and ‘Ox’ industries to improve their resource allocation ability 
and innovation productivity, which might take a longer time to catch.  
1.4 Concluding Remarks 
This study applied the CCR (which is designed under the assumption that 
production exhibits constant returns to scale) and BCC (which assumes that there 
are variable returns to scale) DEA models to evaluate the relative efficiency of R&D 
investments in China’s high-tech industries. The principal econometric inputs 
employed were R&D expenditure, R&D personnel full-time equivalent (FTE), and the 
accumulated patents stock. Three main outputs were selected: the number of 
applied patents number, the value-added from new products and the sale revenue 
for new products. The subsequent analysis was conducted at three different levels: 
across the entire high-tech industry, across the five major high-tech sectors, and 
then across the 16 high-tech sub-sectors, as defined in the source of Chinese 
government data.  
The primary results from this study are that: the R&D investment efficiency in 
China’s high-tech industry was nearly unchanged over test period; most of the 
sectors showed significant fluctuation on R&D investment efficiency over the period; 
average SE increasedamong sub-sectors, and these findings were discussed in more 
detail in the ensuing sections. 
1.4.1 Lack of Immediate Impact of R&D Investment 
The first and most striking result of the analysis at the overall high-tech industry 
level indicates that the R&D investment efficiency in China’s high-tech industry was 
nearly unchanged over the period 1998 to 2009. It is perhaps little surprising that 
the overall R&D investment performance of high-tech industry didn’t show any 
increase, even though the R&D expenditure steadily increased during the 
examination period. Further analysis revealed that the increased R&D expenditure 
was associated with a dramatic increase (see Figure 2.1) in the number of patent 
stock, yet there was a limited increase of the economic return from new products 
over the high-tech industry. This finding suggests that the increase of the R&D 
inputs has brought the obvious improvement of the technology production 
efficiency, but that hasn’t yet led to an equivalent improvement in the efficiency of 
the technology commercialization. This may be one reason why the R&D investment 
of the whole high-tech industry did not perform better during the study period. 
1.4.2 Variable and Fluctuating Performance across Sectors 
Most of the sectors showed significant fluctuation on R&D investment efficiency 
over the period. All of them except the Instrument sector were suffered from DRS in 
most test years.  The Computer sector performed the highest on R&D investment 
efficiency but declined since 2006. Both Electronics and Instrument sectors showed 
the potential of being the most R&D investment efficient sectors in China. The R&D 
investment efficiency of the Aerospace sector was lowest among the five sectors in 
China. 
There are three indices observed through DEA analysis: TE score, PTE score and SE 
score.For TE score, the Computer sector (CAOE) was highest for many years. The 
Electronics sector (EEACE) and the Instrument sector (MEAMI) performed well 
following the Computer sector. Aerospace (AAS) performed lowest of the five high-
tech sectors. However the TE score of the Computer sector started to decline in 
2006. Compared with the decline of computer sector, Electronics and Instrument 
sectors experienced an improvement of TE scores over period. 
The PTE scores showed a similar pattern to the TE analysis. The Computer sector 
achieved the highest and most consistent PTE scores during 1998 to 2008. 
Electronics sector were second highest but unstable over the period. All the other 
three sectors showed an improvement in their PTE scores. And the Aerospace sector 
still owned the lowest PET scores, similar to the TE results.  
Scale efficiency (SE) scores didn’t show any consistent pattern of change across the 
sectors during this period. SE was highest in the Medicine sector, followed by 
Instrument and Computer sectors (see Table 2.8 and Fig. 2.4). The average SE 
scores of the Electronics sector was the lowest of all the high-tech sectors although 
it has begun to increase since 2005. And at the same time, the SE score of the 
Computer sector started to decline in 2006. Further analysis of the SE data 
indicated that China’s high-tech sectors suffered from DRS for most of the test 
period, with the exception of the Instrument sector.  
1.4.3 Average SE Increased Among Sub-sectors 
Sixteen high-tech second-class sub-sectors were chosen and tested. The result 
comparison between 2001 and 2008 showed that, their R&D investment efficiencies 
changed dramatically. Their average TE score decreased with the decreasing 
average PTE score. The average SE scores across the sub-sectors however, were 
increasing. At the same time, sub-sectors were suffering from the decreasing 
returns to scale.  
1.4.4 Summary Conclusion 
In summary, China’s high-tech industries would still appear to need time to improve 
their R&D investment efficiency. In the past, many Chinese scholars and 
government officials have argued that China’s high-tech industries should first 
increase their R&D investment to the level or close to the level of that in developed 
countries, in order to reach the same scientific and technological level of western 
countries (Zhong et al., 2011). However, the DEA analysis of this study illustrates 
that despite a continuous increase of the R&D investment input, the efficiency of 
the R&D investment has not yet showed a clear and consistent improvement. On the 
contrary, more sectors and sub-sectors suffered from the decreasing returns to 
scale, which may be due to the low absorptive capacity for the potential outputs of 
the increasing R&D inputs.  
On the other hand, some scholars and government officials have emphasized that 
China needs to enhance the capacity for independent innovation. However, 
comparing the huge increase of the applied patents number with the unchanged 
R&D investment efficiency, the conclusion is that the problem of China’s high-tech 
industry may not be its lack of independent innovation, but the inefficiency of its 
technology commercialization processes. Of course, this low commercialization 
performance may stem from low quality of independent innovation. This hypothesis 
could be examined in further research, by the study of innovation productivity 
process in China’s high-tech industry. 
 
 
 
References  
Avkiran, N. K., Rowlands, T., 2008. How to better identify the true managerial 
performance: State of the art using DEA. Omega 36, 317-324. 
Banker, R. D., Charnes, A., Cooper, W. W., 1984. Some models for the Estimation of 
Technical and Scale Inefficiencies in Data Envelopment Analysis. Management 
Science 30, 1078-1092. 
Cainelli, G., Evangelista, R., Savona, M., 2006. Innovation and economic 
performance in services: a firm-level analysis. Cambridge Journal of Economics 30, 
435–458 
Charnes, A., Cooper, W. W., Rhodes, E., 1978. Measuring the Efficiency of Decision 
Making Units. European Journal of Operations Research 2, 429-444. 
Chen, C.J., Wu, H.L., Lin, B.W., 2006. Evaluating the development of high-tech 
industries: Taiwan’s science park. Technological Forecasting &Social Change 73, 
452-465. 
Cooper, W. W., Seiford, L.M., Zhu, J., 2004. Handbook on Data Envelopment 
Analysis.Springer. Boston. 
Furman, J.L., Porter, M.E., Stern, S., 2002. The determinants of national innovative 
capacity. Research Policy 31, 899-933. 
Grossman, G., Helpman, E., 1991. Innovation and growth in the global economy. MA: 
MIT Press. Cambridge. 
Guan, J.C., Chen, K.H., 2010.Measuring the innovation production process: A cross-
region empirical study of China’s high-tech innovations.Technovation 30, 348-358. 
Gulati, R., 2011. Evaluation of technical, pure technical and scale efficiencies of 
Indian banks: An analysis from cross-sectional perspective. The 13th Annual 
Conference on Money and Finance in the Indian Economy. 
Hollanders, H., Celikel-Esser, F., 2007.Measuring innovation efficiency. INNO Metrics 
2007 report, Brussels: European Commission, DG Enterprise. 
Hu, M.C., Mathews, J.A., 2008. China’s national innovative capacity. Research Policy 
37, 1465-1479. 
Kozmetsky, G., Yue, P., 1998. Comparative performance of global semiconductor 
companies. Omega 26, 153-175. 
Iglesias, G., Castellanos, P., Seijas, A., 2010. Measurement of productive efficiency 
with frontier methods: A case study for wind farms. Energy Economics 32, 1199-
1208. 
Ministry of Science and Technology of the People’s Republic of China, 2009.China 
Science and Technology Indicators 2008.Scientific and Technical Documents 
Publishing House. Beijing. 
Ministry of Science and Technology of the People’s Republic of China, 2007.China 
Science and Technology Indicators 2006.Scientific and Technical Documents 
Publishing House. Beijing. 
Ministry of Science and Technology of the People’s Republic of China, 2001.China 
Science and Technology Indicators 2000.Scientific and Technical Documents 
Publishing House. Beijing. 
Reinhard, S., Lovell, C. A. K., Thijssen, G. J., 2000. Environmental efficiency with 
multiple environmentally detrimental variables: estimated with SFA and DEA. 
European Journal of Operational Research 121, 287-303. 
Romer, P., 1990.Endogenous technological change. Journal of Political Economy 98, 
71-102. 
Rosegger, G., 1996. The Economics of Production and Innovation.Butterworth-
Heinemann. Oxford. 
Rousseau, S., Rousseau, R., 1997.Data envelopment analysis as a tool for 
constructing scientometrics indicators.Scientometrics 40, 45-56. 
Rousseau, S., Rousseau, R., 1998. The scientific wealth of European nations: taking 
effectiveness into account. Scientometrics 42, 75-87. 
Sharma, S., Thomas, V. J., Inter-country R&D efficiency analysis: An application of 
data envelopment analysis. Scientometrics 76, 483-501. 
The Royal society, 2011. Knowledge, networks and nations: Global scientific 
collaboration in 21st century. Elsevier. London. 
Wang, E. C., Huang, W., 2007. Relative efficiency of R&D activities: A cross-country 
study accounting for environmental factors in the DEA approach. Research Policy 36, 
260-273. 
Xing, Y. Q., 2011. China’s High-tech exports: Myth and Reality. GRIPS Discussion 
Paper. 
Yeh, Q., 1996. The application of data envelopment analysis in conjunction with 
financial ratios for bank performance evaluation.  Journal of Operational Society 47, 
980-988. 
Zabala-Iturriagagoitia, J.M., Voigt, P., Gutierrez-Gracia, A., Jimenez-Saez, F., 2007. 
Regional innovation systems: how to assess performance. Regional Studies 41, 661-
672. 
Zhong, W., Yuan, W., Li, S.X., Huang, Z.M., 2011. The performance evaluation of 
regional R&D investments in China: An application of DEA based on the first official 
China economic census data. Omega 39, 447-455. 
